Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Gizem Akçay, Matthew A. Belmonte, Brian Aquila, et al.
Nature Chemical Biology (2016) Vol. 12, Iss. 11, pp. 931-936
Closed Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer, Stefan Laufer
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 12, pp. 5673-5724
Closed Access | Times Cited: 584
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron, Matthew A. Belmonte, Ammar Adam, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 439
Global profiling of lysine reactivity and ligandability in the human proteome
Stephan M. Hacker, Keriann M. Backus, Michael R. Lazear, et al.
Nature Chemistry (2017) Vol. 9, Iss. 12, pp. 1181-1190
Open Access | Times Cited: 407
Structure-based design of targeted covalent inhibitors
Richard Lonsdale, Richard A. Ward
Chemical Society Reviews (2018) Vol. 47, Iss. 11, pp. 3816-3830
Closed Access | Times Cited: 292
The versatility of boron in biological target engagement
Diego B. Diaz, Andrei K. Yudin
Nature Chemistry (2017) Vol. 9, Iss. 8, pp. 731-742
Closed Access | Times Cited: 276
Advances in covalent kinase inhibitors
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 257
Boronic acids as building blocks for the construction of therapeutically useful bioconjugates
João P. M. António, Roberto Russo, Cátia Parente Carvalho, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 13, pp. 3513-3536
Open Access | Times Cited: 248
Targeting MCL-1 in cancer: current status and perspectives
Haolan Wang, Ming Guo, Hudie Wei, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 238
Lysine‐Targeting Covalent Inhibitors
Jonathan Pettinger, Keith Jones, Matthew D. Cheeseman
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 48, pp. 15200-15209
Closed Access | Times Cited: 196
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
Tomonori Tamura, Tsuyoshi Ueda, Taiki Goto, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 196
A proteome-wide atlas of lysine-reactive chemistry
Mikail E. Abbasov, Madeline E. Kavanagh, Taka-Aki Ichu, et al.
Nature Chemistry (2021) Vol. 13, Iss. 11, pp. 1081-1092
Open Access | Times Cited: 182
Lysine-Targeting Reversible Covalent Inhibitors with Long Residence Time
Rahi M. Reja, Wenjian Wang, Yuhan Lyu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 3, pp. 1152-1157
Open Access | Times Cited: 74
Proteomic discovery of chemical probes that perturb protein complexes in human cells
Michael R. Lazear, Jarrett R. Remsberg, Martin G. Jaeger, et al.
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1725-1742.e12
Open Access | Times Cited: 67
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 55
An update on the discovery and development of reversible covalent inhibitors
Faridoon Faridoon, Raymond Ng, Guiping Zhang, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1039-1062
Open Access | Times Cited: 46
A study of the reactivity of S(VI)–F containing warheads with nucleophilic amino-acid side chains under physiological conditions
H. G. MUKHERJEE, J.E. Debreczeni, J. Breed, et al.
Organic & Biomolecular Chemistry (2017) Vol. 15, Iss. 45, pp. 9685-9695
Closed Access | Times Cited: 128
Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
Simona D’Aguanno, Donatella Del Bufalo
Cells (2020) Vol. 9, Iss. 5, pp. 1287-1287
Open Access | Times Cited: 125
Recent advances in the development of Mcl-1 inhibitors for cancer therapy
Alexander W. Hird, Adriana E. Tron
Pharmacology & Therapeutics (2019) Vol. 198, pp. 59-67
Open Access | Times Cited: 123
Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue
Olugbeminiyi Fadeyi, Lise R. Hoth, Chulho Choi, et al.
ACS Chemical Biology (2017) Vol. 12, Iss. 8, pp. 2015-2020
Closed Access | Times Cited: 122
Covalent inhibitors: an opportunity for rational target selectivity
Roman Lagoutte, Rémi Patouret, Nicolas Winssinger
Current Opinion in Chemical Biology (2017) Vol. 39, pp. 54-63
Open Access | Times Cited: 119
Visualizing and trapping transient oligomers in amyloid assembly pathways
Emma E. Cawood, Theodoros K. Karamanos, Andrew J. Wilson, et al.
Biophysical Chemistry (2020) Vol. 268, pp. 106505-106505
Open Access | Times Cited: 116
Selective and reversible modification of kinase cysteines with chlorofluoroacetamides
Naoya Shindo, Hirokazu Fuchida, Mami Sato, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 3, pp. 250-258
Closed Access | Times Cited: 115
Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Luca Gambini, Carlo Baggio, Parima Udompholkul, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 11, pp. 5616-5627
Open Access | Times Cited: 114
Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors
Ruibin Liu, Zhi Yue, Cheng‐Chieh Tsai, et al.
Journal of the American Chemical Society (2019) Vol. 141, Iss. 16, pp. 6553-6560
Open Access | Times Cited: 113
Lysine-Targeted Inhibitors and Chemoproteomic Probes
Adolfo Cuesta, Jack Taunton
Annual Review of Biochemistry (2019) Vol. 88, Iss. 1, pp. 365-381
Open Access | Times Cited: 104
Page 1 - Next Page

Scroll to top